Results 221 to 230 of about 331,966 (252)
Some of the next articles are maybe not open access.

Medicare Spending on Anti–Vascular Endothelial Growth Factor Medications

Ophthalmology Retina, 2018
To analyze Medicare Part B spending on anti-vascular endothelial growth factor (VEGF) medications.Observational cohort study using Medicare Part B claims data released by the Centers for Medicare and Medicaid Services.Medicare Part B beneficiaries and their providers.Data from 2011 through 2015 were used to analyze intravitreal injection claims for ...
openaire   +2 more sources

Anti-Vascular Endothelial Growth Factor Monoclonal Antibodies

2009
As tumors grow and metastasize, they require the formation of new blood vessels or angiogenesis. This process is regulated by a complex balance of pro- and antiangiogenic factors. One of these factors, vascular endothelial growth factor (VEGF), has been extensively studied and found to be an important stimulatory signal that drives angiogenesis.
Ernest S. Han, Bradley J. Monk
openaire   +1 more source

Anti-Vascular Endothelial Growth Factor Treatment for Retinal Vein Occlusions

Ophthalmologica, 2012
Retinal vein occlusion (RVO) encompasses two conditions: central RVO, in which the major outflow vessel of the retina is obstructed, and branch RVO, in which a proximal branch of the central retinal vein is obstructed. In both conditions, there is increased intraluminal and interstitial pressure throughout the retina drained by the obstructed vessels ...
openaire   +2 more sources

Antivascular Endothelial Growth Factor

2015
Michelle C. Liang, Jeffrey S. Heier
openaire   +1 more source

Vascular Endothelial Growth Factor, a Key Modulator of the Anti-Tumor Immune Response

International Journal of Molecular Sciences, 2021
Melanie Bruchard   +2 more
exaly  

Rescue photodynamic therapy for age-related macular degeneration refractory to anti-vascular endothelial growth factor monotherapy

Photodiagnosis and Photodynamic Therapy, 2022
Akitaka Tsujikawa   +2 more
exaly  

Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy

Cancer Treatment and Research Communications, 2022
Oluwafemi Adeleke Ojo   +2 more
exaly  

Home - About - Disclaimer - Privacy